The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Open accessAbstract
A major resistance mechanism in Gram-negative bacteria is the production of β-lactamase enzymes. Originally recognized for their ability to hydrolyze penicillins, emergent β-lactamases can now confer resistance to other β-lactam drugs, including both cephalosporins and carbapenems. The emergence and global spread of β-lactamase-producing multi-drug-resistant “superbugs” has caused increased alarm within the medical community due to the high mortality rate associated with these difficult-to-treat bacterial infections. To address this unmet medical need, we initiated an iterative program combining medicinal chemistry, structural biology, biochemical testing, and microbiological profiling to identify broad-spectrum inhibitors of both serine- and metallo-β-lactamase enzymes. Lead optimization, beginning with narrower-spectrum, weakly active compounds, provided 20 (VNRX-5133, taniborbactam), a boronic-acid-containing pan-spectrum β-lactamase inhibitor. In vitro and in vivo studies demonstrated that 20 restored the activity of β-lactam antibiotics against carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae. Taniborbactam is the first pan-spectrum β-lactamase inhibitor to enter clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,317
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7
Langer, G., Cohen, S. X., Lamzin, V. S., & Perrakis, A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.91 · Cited by 1,606
Predictive compound accumulation rules yield a broad-spectrum antibiotic
Richter, M. F., Drown, B. S., Riley, A. P., Garcia, A., Shirai, T., Svec, R. L., & Hergenrother, P. J. (2017) · Nature · doi:10.1038/nature22308 · Cited by 891
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Industrial production of β-lactam antibiotics
Elander, R. P. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1274-y · Cited by 559
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Kern, G., Walkup, G. K., & Fisher, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205073109 · Cited by 545
Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution
Strynadka, N. C. J., Adachi, H., Jensen, S. E., Johns, K., Sielecki, A., Betzel, C., Sutoh, K., & James, M. N. G. (1992) · Nature · doi:10.1038/359700a0 · Cited by 525
Metallo‐β‐lactamase structure and function
Palzkill, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06796.x · Cited by 505
Boron Containing Compounds as Protease Inhibitors
Smoum, R., Rubinstein, A., Dembitsky, V. M., & Srebnik, M. (2012) · Chemical Reviews · doi:10.1021/cr608202m · Cited by 450
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Brem, J., Cain, R., Cahill, S., McDonough, M. A., Clifton, I. J., Jiménez-Castellanos, J.-C., Avison, M. B., Spencer, J., Fishwick, C. W. G., & Schofield, C. J. (2016) · Nature Communications · doi:10.1038/ncomms12406 · Cited by 255
Lahiri, S. D., Mangani, S., Durand-Reville, T., Benvenuti, M., De Luca, F., Sanyal, G., & Docquier, J.-D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02247-12 · Cited by 230
Self-citationBicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases
Krajnc, A., Brem, J., Hinchliffe, P., Calvopiña, K., Panduwawala, T. D., Lang, P. A., Kamps, J. J. A. G., Tyrrell, J. M., Widlake, E., Saward, B. G., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00911 · Cited by 218
Morinaka, A., Tsutsumi, Y., Yamada, M., Suzuki, K., Watanabe, T., Abe, T., Furuuchi, T., Inamura, S., Sakamaki, Y., Mitsuhashi, N., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv166 · Cited by 183
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design
Linciano, P., Cendron, L., Gianquinto, E., Spyrakis, F., & Tondi, D. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00247 · Cited by 173
On functional and structural heterogeneity of VIM-type metallo-beta-lactamases
Docquier, J.-D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg067 · Cited by 167
Self-citationNew β-Lactamase Inhibitors in the Clinic
Papp-Wallace, K. M., & Bonomo, R. A. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.007 · Cited by 162
The inhibition of class C β-lactamases by boronic acids
Beesley, T., Gascoyne, N., Knott-Hunziker, V, Petursson, S., Waley, S. G., Jaurin, B., & Grundström, T. (1983) · Biochemical Journal · doi:10.1042/bj2090229 · Cited by 159
Reversible inhibitors of penicillinases
Kiener, P. A., & Waley, S. G. (1978) · Biochemical Journal · doi:10.1042/bj1690197 · Cited by 139
Cyclic Boronates Inhibit All Classes of β-Lactamases
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., Spencer, J., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02260-16 · Cited by 135
Ness, S. R., Martin, R., Kindler, A. M., Paetzel, M., Gold, M. H., Jensen, S. E., Jones, J. B., & Strynadka, N. C. J. (2000) · Biochemistry · doi:10.1021/bi992505b · Cited by 133
Nanomolar Inhibitors of AmpC β-Lactamase
Morandi, F., Caselli, E., Morandi, S., Focia, P. J., Blázquez, J., Shoichet, B. K., & Prati, F. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0288338 · Cited by 130
Will morphing boron-based inhibitors beat the β-lactamases?
Krajnc, A., Lang, P. A., Panduwawala, T., Brem, J., & Schofield, C. J. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.03.001 · Cited by 97
Cyclic Boronates Inhibit All Classes of β-Lactamase
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., SPENCER, J. M., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 91
Structure-based design of a potent transition state analogue for TEM-1 β-lactamase
Strynadka, N. C. J., Martin, R., Jensen, S. E., Gold, M. H., & Jones, J. B. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-688 · Cited by 89
Docquier, J.-D., Benvenuti, M., Calderone, V., Stoczko, M., Menciassi, N., Rossolini, G. M., & Mangani, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00409-10 · Cited by 51
Self-citationRecognition and Resistance in TEM β-Lactamase
Wang, X., Minasov, G., Blázquez, J., Caselli, E., Prati, F., & Shoichet, B. K. (2003) · Biochemistry · doi:10.1021/bi034242y · Cited by 47
Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates
Cahill, S. T., Tyrrell, J. M., Navratilova, I. H., Calvopiña, K., Robinson, S. W., Lohans, C. T., McDonough, M. A., Cain, R. M., Fishwick, C. W. G., Avison, M. B., et al. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.02.004 · Cited by 33
Watkins, R., & Bonomo, R. A. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.46 · Cited by 30
Atomic‐Resolution Structure of a Class C β‐Lactamase and Its Complex with Avibactam
Pozzi, C., Pisa, F. D., Luca, F. D., Benvenuti, M., Docquier, J., & Mangani, S. (2018) · ChemMedChem · doi:10.1002/cmdc.201800213 · Cited by 18
Self-citation
Cited by
The Science of Antibiotic Discovery
Lewis, K. (2020) · Cell · doi:10.1016/j.cell.2020.02.056 · Cited by 797
Grams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Bita, A., Cerecetto, H., Viñas, C., & Soriano-Ursúa, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 377
Critical analysis of antibacterial agents in clinical development
Theuretzbacher, U., Bush, K., Harbarth, S., Paul, M., Rex, J. H., Tacconelli, E., & Thwaites, G. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0340-0 · Cited by 373
Bahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Antibiotics in the clinical pipeline in October 2019
Butler, M. S., & Paterson, D. L. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0291-8 · Cited by 264
Metadata
- Authors
- Liu, B., Trout, R. E. L., Chu, G.-H., McGarry, D., Jackson, R. W., Hamrick, J. C., Daigle, D. M., Cusick, S. M., Pozzi, C., De Luca, F., Benvenuti, M., Mangani, S., Docquier, J.-D., Weiss, W. J., Pevear, D. C., Xerri, L., & Burns, C. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-11-25
- Volume
- 63
- Issue
- 6
- Pages
- 2789-2801
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2990621521
- Cited by
- 312
- References
- 34
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.